Cargando…

Letter to the Editor From Sävendahl et al.: “Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial”

Detalles Bibliográficos
Autores principales: Sävendahl, Lars, Battelino, Tadej, Brod, Meryl, Højby Rasmussen, Michael, Juul Kildemoes, Rasmus, Saenger, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764219/
https://www.ncbi.nlm.nih.gov/pubmed/34626473
http://dx.doi.org/10.1210/clinem/dgab736
_version_ 1784634115791781888
author Sävendahl, Lars
Battelino, Tadej
Brod, Meryl
Højby Rasmussen, Michael
Juul Kildemoes, Rasmus
Saenger, Paul
author_facet Sävendahl, Lars
Battelino, Tadej
Brod, Meryl
Højby Rasmussen, Michael
Juul Kildemoes, Rasmus
Saenger, Paul
author_sort Sävendahl, Lars
collection PubMed
description
format Online
Article
Text
id pubmed-8764219
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-87642192022-01-19 Letter to the Editor From Sävendahl et al.: “Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial” Sävendahl, Lars Battelino, Tadej Brod, Meryl Højby Rasmussen, Michael Juul Kildemoes, Rasmus Saenger, Paul J Clin Endocrinol Metab Online Only Articles Oxford University Press 2021-10-09 /pmc/articles/PMC8764219/ /pubmed/34626473 http://dx.doi.org/10.1210/clinem/dgab736 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Online Only Articles
Sävendahl, Lars
Battelino, Tadej
Brod, Meryl
Højby Rasmussen, Michael
Juul Kildemoes, Rasmus
Saenger, Paul
Letter to the Editor From Sävendahl et al.: “Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial”
title Letter to the Editor From Sävendahl et al.: “Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial”
title_full Letter to the Editor From Sävendahl et al.: “Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial”
title_fullStr Letter to the Editor From Sävendahl et al.: “Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial”
title_full_unstemmed Letter to the Editor From Sävendahl et al.: “Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial”
title_short Letter to the Editor From Sävendahl et al.: “Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial”
title_sort letter to the editor from sävendahl et al.: “weekly lonapegsomatropin in treatment-naïve children with growth hormone deficiency: the phase 3 height trial”
topic Online Only Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764219/
https://www.ncbi.nlm.nih.gov/pubmed/34626473
http://dx.doi.org/10.1210/clinem/dgab736
work_keys_str_mv AT savendahllars lettertotheeditorfromsavendahletalweeklylonapegsomatropinintreatmentnaivechildrenwithgrowthhormonedeficiencythephase3heighttrial
AT battelinotadej lettertotheeditorfromsavendahletalweeklylonapegsomatropinintreatmentnaivechildrenwithgrowthhormonedeficiencythephase3heighttrial
AT brodmeryl lettertotheeditorfromsavendahletalweeklylonapegsomatropinintreatmentnaivechildrenwithgrowthhormonedeficiencythephase3heighttrial
AT højbyrasmussenmichael lettertotheeditorfromsavendahletalweeklylonapegsomatropinintreatmentnaivechildrenwithgrowthhormonedeficiencythephase3heighttrial
AT juulkildemoesrasmus lettertotheeditorfromsavendahletalweeklylonapegsomatropinintreatmentnaivechildrenwithgrowthhormonedeficiencythephase3heighttrial
AT saengerpaul lettertotheeditorfromsavendahletalweeklylonapegsomatropinintreatmentnaivechildrenwithgrowthhormonedeficiencythephase3heighttrial